Showing results (341-350 of 406) with videos related to
Sort By:
Pageof 41
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 25, 2022
Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver diseaseKatharina Pomej, Bernhard Scheiner, Lorenz Balcar, et al.JHEP Reports : Innovation in Hepatology|July 18, 2022
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation eventLorenz Balcar, Marta Tonon, Georg Semmler, et al.Journal of Neurointerventional Surgery|September 9, 2020
Impact of off-hour endovascular therapy on outcomes for acute ischemic stroke: insights from STARChristine Tschoe, Carol Kittel, Patrick Brown, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 23, 2026
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in CirrhosisNikolaus Pfisterer, Irina Lie-Ungurean, Jurij Maurer, et al.JHEP Reports : Innovation in Hepatology|September 30, 2022
Alpha-1 antitrypsin Pi∗Z allele is an independent risk factor for liver transplantation and death in patients with advanced chronic liver diseaseLorenz Balcar, Bernhard Scheiner, Markus Urheu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2026
Trop-2.2 directed radioimmunotherapy with 177Lu, 225Ac, and 212Pb in a pancreatic cancer modelEdwin C Pratt, David Bauer, Lukas M Carter, et al.Journal of Medicinal Chemistry|April 18, 2018
Nε-Acryloyllysine Piperazides as Irreversible Inhibitors of Transglutaminase 2: Synthesis, Structure-Activity Relationships, and Pharmacokinetic ProfilingRobert Wodtke, Christoph Hauser, Gloria Ruiz-Gómez, et al.Plos One|January 10, 2018
Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding - A two decades experienceTheresa Bucsics, Maria Schoder, Magdalena Diermayr, et al.United European Gastroenterology Journal|September 4, 2020
Soluble guanylyl cyclase stimulation and phosphodiesterase-5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct-ligated ratsKsenia Brusilovskaya, Philipp Königshofer, Daniel Lampach, et al.Pediatric Blood & Cancer|September 17, 2015
Activity and Toxicity of Intravenous Erwinia Asparaginase Following Allergy to E. coli-Derived Asparaginase in Children and Adolescents With Acute Lymphoblastic LeukemiaLynda M Vrooman, Ivan I Kirov, ZoAnn E Dreyer, et al.Pageof 41